110 results
SC 14D9
TXMD
TherapeuticsMD Inc
10 Jun 22
Tender offer solicitation
6:51pm
value of debt, plus minority interest, less cash and cash equivalents, less investments in unconsolidated affiliates, as a multiple of estimated fiscal
POS AM
23ytfm9oeth 5j3
23 Mar 22
Prospectus update (post-effective amendment)
6:06pm
POSASR
g7s1p cu1sw4ji4stbu
23 Mar 22
Automatic shelf registration (post-effective amendment)
4:37pm
8-K
EX-99.2
fvvrnx45yu
4 Aug 21
TherapeuticsMD Announces Second Quarter 2021 Financial Results
7:00am
8-K
EX-99.1
onuh7hf
4 Aug 21
TherapeuticsMD Announces Second Quarter 2021 Financial Results
7:00am
S-3ASR
5xg up1buj
4 Mar 21
Automatic shelf registration
12:00am
8-K
EX-99.2
ue63tc
2 Mar 21
TherapeuticsMD Announces Fourth Quarter and Full-Year 2020 Financial Results
7:00am
8-K
EX-99.2
4bw gajru
9 Nov 20
TherapeuticsMD® Announces Third Quarter 2020 Financial Results
6:55am
POS AM
3hgaue5m6fv 05p
24 Feb 20
Prospectus update (post-effective amendment)
4:56pm
POSASR
c36apxx8w9peiusfy
24 Feb 20
Automatic shelf registration (post-effective amendment)
4:09pm